5-Minute Clinical Consult

Salivary Gland Tumors

Salivary Gland Tumors was found in 5-Minute Clinical Consult which helps you diagnose, treat, and follow up on over 900 medical conditions seen in everyday practice.

To view this entire topic, please or purchase a subscription.

Explore 5-Minute Clinical Consult - view these FREE monographs:

5-Minute Clinical Consult

-- The first section of this topic is shown below --

Basics

Salivary gland tumors consist of benign or malignant neoplasms of the major and minor salivary glands. Tumors may be mimicked clinically by a variety of inflammatory or infectious disorders:

  • Major: Parotid, submaxillary, sublingual glands
  • Minor: Intraoral, pharyngeal, and nasal glands (600–1,000 glands distributed throughout the upper aerodigestive tract)

Description

  • Adult neoplasms:
    • Benign: Pleomorphic adenoma, Warthin tumor (adenolymphoma), oncocytoma, and monomorphic adenoma
    • Malignant: Mucoepidermoid carcinoma, adenoid cystic carcinoma, acinic cell carcinoma, carcinoma ex-pleomorphic adenoma, squamous cell carcinoma (SCC), adenocarcinoma
  • Total distribution of salivary gland neoplasms by type:
    • Pleomorphic adenoma (most common): 45% overall
    • Monomorphic adenoma: 12% overall
    • Mucoepidermoid carcinoma: 12% overall
    • Adenoid cystic carcinoma: 6% overall
    • Remaining neoplasms: 25% overall
  • Distribution: Parotid (80%); submandibular (10–15%); sublingual and minor (5–10%):
    • Parotid (80% benign; 20% malignant):
      • Pleomorphic adenoma: 60%
      • Monomorphic adenoma: 8%
      • Warthin tumor: 8%
      • Mucoepidermoid carcinoma: 12%
      • Adenoid cystic carcinoma: 5%
      • Adenocarcinoma and SCC: 5%
    • Submandibular (60% benign; 40% malignant):
      • Pleomorphic adenoma: 40%
      • Mucoepidermoid carcinoma: 10%
      • Adenoid cystic carcinoma: 20%
    • Lingual and minor salivary glands (40% benign; 60% malignant):
      • Pleomorphic adenoma: 40%
      • Mucoepidermoid carcinoma: 25%
      • Adenoid cystic carcinoma: 25%; generally, as the size of the neoplasm decreases, the incidence of malignancy increases.
  • Pediatric neoplasms:
    • These tumors are most frequently benign, but may be malignant.
    • Benign: 65% of overall cases; the most common types are hemangiomas and pleomorphic adenomas.
    • Malignant: 35% of overall cases; most common type is mucoepidermoid carcinoma.

Epidemiology


Incidence
  • 1.5 cases per 100,000 individuals in the US
  • ~700 deaths annually
  • Median age:
    • Benign: 45 years
    • Malignant: 60 years
  • Gender predilection:
    • Benign: Female > Male
    • Malignant: Male = Female

Prevalence
Make up 6–8% of all head and neck neoplasms (1)

Risk Factors

  • Tobacco and alcohol abuse associated with Warthin tumor, but not with SCC
  • Alcohol increases likelihood ratio by 2:1 (2).
  • Radiation has shown a 4-fold increased dose-related response in salivary gland cancer 15–20 years after treatment. Increased risk has also been reported in atomic bomb survivors (2).
  • EBV has been associated with lymphoepithelial carcinoma in Asians, but there is no evidence of causal association in other tumors (2).
  • Silica dust has been associated with a 2.5-fold increase in salivary gland neoplasia (2).
  • Kerosene cooking fuel exposure (2)
  • Nitrosamine exposure in rubber workers (2)
  • Early menarche and nulliparity (2)

Genetics
Increased incidence of adenocarcinoma of parotid in Eskimos; otherwise, no known genetic pattern

General Prevention

Cessation of tobacco and alcohol use

Pathophysiology

Pathophysiology not fully understood; certain pathways and oncogenes have been implicated: p53, Bcl-2, PI3K/Akt, MDM2, VEGF, HGF, and ras.

Etiology

  • Etiology is not fully understood.
  • Predominant theory: Tumors arise from either the secretory duct reserve cell or the intercalated duct reserve cell.

-- To view the remaining sections of this topic, please or purchase a subscription --